Biddle Warner Weston 4
4 · Kyverna Therapeutics, Inc. · Filed Sep 18, 2024
Insider Transaction Report
Form 4
Biddle Warner Weston
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-09-16+2,579,259→ 2,579,259 totalExercise: $6.89Exp: 2034-09-16→ Common Stock (2,579,259 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on September 16, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.